全文获取类型
收费全文 | 859篇 |
免费 | 56篇 |
国内免费 | 2篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 51篇 |
妇产科学 | 17篇 |
基础医学 | 130篇 |
口腔科学 | 26篇 |
临床医学 | 117篇 |
内科学 | 220篇 |
皮肤病学 | 14篇 |
神经病学 | 57篇 |
特种医学 | 33篇 |
外科学 | 66篇 |
综合类 | 15篇 |
一般理论 | 1篇 |
预防医学 | 60篇 |
眼科学 | 32篇 |
药学 | 45篇 |
1篇 | |
肿瘤学 | 31篇 |
出版年
2023年 | 16篇 |
2022年 | 9篇 |
2021年 | 19篇 |
2020年 | 13篇 |
2019年 | 21篇 |
2018年 | 20篇 |
2017年 | 9篇 |
2016年 | 21篇 |
2015年 | 19篇 |
2014年 | 18篇 |
2013年 | 26篇 |
2012年 | 39篇 |
2011年 | 44篇 |
2010年 | 24篇 |
2009年 | 29篇 |
2008年 | 42篇 |
2007年 | 23篇 |
2006年 | 28篇 |
2005年 | 28篇 |
2004年 | 34篇 |
2003年 | 17篇 |
2002年 | 19篇 |
2001年 | 19篇 |
2000年 | 17篇 |
1999年 | 21篇 |
1998年 | 16篇 |
1997年 | 21篇 |
1996年 | 14篇 |
1995年 | 15篇 |
1994年 | 14篇 |
1993年 | 10篇 |
1992年 | 14篇 |
1991年 | 24篇 |
1990年 | 16篇 |
1989年 | 18篇 |
1988年 | 25篇 |
1987年 | 11篇 |
1986年 | 10篇 |
1985年 | 9篇 |
1984年 | 9篇 |
1983年 | 9篇 |
1982年 | 10篇 |
1981年 | 11篇 |
1979年 | 6篇 |
1978年 | 7篇 |
1977年 | 13篇 |
1976年 | 9篇 |
1974年 | 11篇 |
1973年 | 13篇 |
1972年 | 5篇 |
排序方式: 共有917条查询结果,搜索用时 343 毫秒
901.
Arendrup MC Bruun B Christensen JJ Fuursted K Johansen HK Kjaeldgaard P Knudsen JD Kristensen L Møller J Nielsen L Rosenvinge FS Røder B Schønheyder HC Thomsen MK Truberg K 《Journal of clinical microbiology》2011,49(1):325-334
A 6-year nationwide study of fungemia in Denmark was performed using data from an active fungemia surveillance program and from laboratory information systems in nonparticipating regions. A total of 2,820 episodes of fungemia were recorded. The incidence increased from 2004 to 2007 (7.7 to 9.6/100,000) and decreased slightly from 2008 to 2009 (8.7 to 8.6/100,000). The highest incidences were seen at the extremes of age (i.e., 11.3 and 37.1/100,000 for those <1 and 70 to 79 years old, respectively). The rate was higher for males than for females (10.1 versus 7.6/100,000, P = 0.003), with the largest difference observed for patients >50 years of age. The species distribution varied significantly by both age and gender. Candida species accounted for 98% of the pathogens, and C. albicans was predominant, although the proportion decreased (64.4% to 53.2%, P < 0.0001). C. glabrata ranked second, and the proportion increased (16.5% to 25.9%, P = 0.003). C. glabrata was more common in adults and females than in children and males, whereas C. tropicalis was more common in males (P = 0.020). C. krusei was a rare isolate (4.1%) except at one university hospital. Acquired resistance to amphotericin and echinocandins was rare. However, resistance to fluconazole (MIC of >4 μg/ml) occurred in C. albicans (7/1,183 [0.6%]), C. dubliniensis (2/65 [3.1%]), C. parapsilosis (5/83 [6.0%]), and C. tropicalis (7/104 [6.7%]). Overall, 70.8% of fungemia isolates were fully fluconazole susceptible, but the proportion decreased (79.7% to 68.9%, P = 0.02). The study confirmed an incidence rate of fungemia in Denmark three times higher than those in other Nordic countries and identified marked differences related to age and gender. Decreased susceptibility to fluconazole was frequent and increasing. 相似文献
902.
U. Snygg-Martin R. V. Rasmussen C. Hassager N. E. Bruun R. Andersson L. Olaison 《European journal of clinical microbiology & infectious diseases》2011,30(2):151-157
Anticoagulant therapy has been anticipated to increase the risk of cerebrovascular complications (CVC) in native valve endocarditis
(NVE). This study investigates the relationship between ongoing oral anticoagulant therapy and the incidence of symptomatic
CVC in left-sided NVE. In a prospective cohort study, the CVC incidence was compared between NVE patients with and without
ongoing warfarin. Among 587 NVE episodes, 48 (8%) occurred in patients on warfarin. A symptomatic CVC was seen in 144 (25%)
patients, with only three on warfarin. CVC were significantly less frequent in patients on warfarin (6% vs. 26%, odds ratio
[OR] 0.20, 95% confidence interval [CI] 0.06–0.6, p = 0.006). No increase in haemorrhagic lesions was detected in patients on warfarin. Staphylococcus aureus aetiology (adjusted OR [aOR] 6.3, 95% CI 3.8–10.4) and vegetation length (aOR 1.04, 96% CI 1.01–1.07) were risk factors for
CVC, while warfarin on admission (aOR 0.26, 95% CI 0.07–0.94), history of congestive heart failure (adjusted OR 0.22, 95%
CI 0.1–0.52) and previous endocarditis (aOR 0.1, 95% CI 0.01–0.79) correlated with lower CVC frequency. 相似文献
903.
B.R. Kittang T. Bruun N. Langeland H. Mylvaganam M. Glambek S. Skrede 《Clinical microbiology and infection》2011,17(3):358-364
Invasive group A streptococcal (iGAS) disease is endemic in Norway, but data on invasive group C and group G streptococcal (iGCS/GGS) disease are lacking. We investigated the characteristics of iGAS and iGCS/GGS infections in western Norway from March 2006 to February 2009. Clinical information was retrospectively obtained from medical records. GAS and GCS/GGS isolates were emm typed and screened for the presence of 11 superantigen (SAg) genes and the gene encoding streptococcal phospholipase A2 (SlaA). GCS/GGS isolates were also subjected to PCR with primers targeting speGdys. Sixty iGAS and 50 iGCS/GGS cases were identified, corresponding to mean annual incidence rates of 5.0 per 100 000 and 4.1 per 100 000 inhabitants, respectively. Skin and soft tissue infections were the most frequent clinical manifestations of both iGAS and iGCS/GGS disease, and 14 iGAS patients (23%) developed necrotizing fasciitis. The 30-day case fatality rates of iGAS and iGCS/GGS disease were 10% and 2%, respectively. emm1, emm3 and emm28 accounted for 53% of the GAS isolates, and these types were associated with severe clinical outcome. SAg gene and SlaA profiles were conserved within most of the GAS emm types, although five profiles were obtained within isolates of emm28. stG643 was the most prevalent GCS/GGS emm type, and speGdys was identified in 73% of the GCS/GGS isolates. Neither GAS SAg genes nor SlaA were detected in GCS/GGS. Our findings indicate a considerable burden of both iGAS and iGCS/GGS disease and a high frequency of necrotizing fasciitis caused by GAS in our community. 相似文献
904.
Sulfatide increases adiponectin and decreases TNF-alpha, IL-6, and IL-8 in human adipose tissue in vitro 总被引:2,自引:0,他引:2
Bruun JM Roeske-Nielsen A Richelsen B Fredman P Buschard K 《Molecular and cellular endocrinology》2007,263(1-2):142-148
Type 2 diabetes is associated with decreased levels of the glycosphingolipid sulfatide, as well as a state of low-grade inflammation. Sulfatide is reported to have anti-inflammatory properties in other cell-types. In the present study, the effects of sulfatide on adipokine (adiponectin, TNF-alpha, IL-6, and IL-8) production in human adipose tissue (AT) was investigated in vitro. Isolated human adipocytes and AT cultures were incubated with sulfatide isolated from pig brain [sulfatide containing a variety of fatty acids or isoforms of sulfatide with defined, saturated fatty acids with 16 (C16:0) or 24 (C24:0) carbon atoms]. Adiponectin production was increased 50-80%, by all sulfatide preparations. Only the C16:0 isoform decreased TNF-alpha, IL-6, and IL-8 production 20-30%. The C16:0 sulfatide has been shown to activate potassium channels in beta-cells, and glibenclamide, an ATP-sensitive K+-(KATP) channel blocker, reversed the C16:0-induced decrement in stimulated TNF-alpha, IL-6, and IL-8 release in adipocytes. Glibenclamide on its own was without effect on the production of adiponectin, TNF-alpha, IL-6, and IL-8. In conclusion, this study shows that, sulfatide exerts anti-inflammatory effects in human adipocytes and AT in vitro. Accordingly, the reported low serum levels of sulfatide in patients with type 2 diabetes might be of importance in relation to the chronic low-grade inflammatory state found in this disease. 相似文献
905.
906.
907.
Morten Hedetoft Martin Bruun Madsen Cecilie Bo Hansen Ole Hyldegaard Peter Garred 《Journal of innate immunity》2022,14(4):355
The hyperinflammatory burden is immense in necrotizing soft-tissue infection (NSTI). The complement system is a key during the innate immune response and may be a promising target to reduce the inflammatory response, potentially improving the clinical outcome. However, complement activation and its association to disease severity and survival remain unknown in NSTI. Therefore, we prospectively enrolled patients with NSTI and sampled blood at admission and once daily for the following 3 days. Plasma C4c, C4d, C3bc, and C3dg and the terminal complement complex (TCC) were evaluated using ELISA techniques. In total, 242 patients were included with a median age of 62 years, with a 60% male predominance. All-cause 30-day mortality was 17% (95% confidence interval [CI] 13–23) with a follow-up of >98%. C4c and C3dg were negatively correlated with Simplified Acute Physiology Score II (Rho −0.22, p < 0.001 and Rho −0.17, p = 0.01). Patients with septic shock (n = 114, 47%) had higher levels of baseline TCC than those in non-shock patients (18 vs. 14, p < 0.001). TCC correlated with the Sequential Organ Failure Assessment (SOFA) score (Rho 0.19, p = 0.004). In multivariate Cox regression analysis (adjusted for age, sex, comorbidity, and SOFA score), high baseline C4d (>20 ng/mL) and the combination of high C4d and TCC (>31 arbitrary units/mL) were associated with increased 30-day mortality (hazard ratio [HR] 3.26, 95% CI 1.56–6.81 and HR 5.12, 95% CI 2.15–12.23, respectively). High levels of both C4d and TCC demonstrated a negative predictive value of 0.87. In conclusion, we found that in patients with NSTI, complement activation correlated with the severity of the disease. High baseline C4d and combination of high C4d and TCC are associated with increased 30-day mortality. Low baseline C4d or TCC indicates a higher probability of survival. 相似文献
908.
909.
Anne Bruun Rovsing Emil Aagaard Thomsen Ian Nielsen Thomas Wisbech Skov Yonglun Luo Karen Dybkær Jacob Giehm Mikkelsen 《British journal of haematology》2023,202(4):825-839
The frontline therapy R-CHOP for patients with diffuse large B-cell lymphoma (DLBCL) has remained unchanged for two decades despite numerous Phase III clinical trials investigating new alternatives. Multiple large studies have uncovered genetic subtypes of DLBCL enabling a targeted approach. To further pave the way for precision oncology, we perform genome-wide CRISPR screening to uncover the cellular response to one of the components of R-CHOP, vincristine, in the DLBCL cell line SU-DHL-5. We discover important pathways and subnetworks using gene-set enrichment analysis and protein–protein interaction networks and identify genes related to mitotic spindle organization that are essential during vincristine treatment. The inhibition of KIF18A, a mediator of chromosome alignment, using the small molecule inhibitor BTB-1 causes complete cell death in a synergistic manner when administered together with vincristine. We also identify the genes KIF18B and USP28 of which CRISPR/Cas9-directed knockout induces vincristine resistance across two DLBCL cell lines. Mechanistic studies show that lack of KIF18B or USP28 counteracts a vincristine-induced p53 response suggesting that resistance to vincristine has origin in the mitotic surveillance pathway (USP28-53BP1-p53). Collectively, our CRISPR screening data uncover potential drug targets and mechanisms behind vincristine resistance, which may support the development of future drug regimens. 相似文献
910.
Abbas Ali Qayyum Bas van Klarenbosch Sabina Frljak Andraz Cerar Gregor Poglajen Denise Traxler-Weidenauer Pawel Nadrowski Christina Paitazoglou Bojan Vrtovec Martin W. Bergmann Steven A. J. Chamuleau Wojtek Wojakowski Mariann Gyöngyösi Adriaan Kraaijeveld Kristian Schultz Hansen Karsten Vrangbæk Erik Jørgensen Steffen Helqvist Francis Richard Joshi Ellen Mønsted Johansen Bjarke Follin Morten Juhl Lisbeth Drozd Højgaard Anders Bruun Mathiasen Annette Ekblond Mandana Haack-Sørensen Jens Kastrup the SCIENCE Investigators 《European journal of heart failure》2023,25(4):576-587